Provida Pension Fund Administrator

Q2 2019 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Elisabeth Bedore - Authorized Signatory
Location
Las Condes, Santiago, Chile
Holdings as of
June 30, 2019
Value $
$2.64M
Num holdings
71
Date filed
12/2/2019, 12:29 PM
Form type
13F-HR/A-3 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included . Request for Confidential Treatment (9/11/2019): Confidential Treatment Expired on 11/15/2019.
Previous filing
Q1 2019 - May 15, 2019
Next filing
Q3 2019 - Feb 28, 2020
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q2 - Restatement compared to 2019 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 09-11-2019 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-15-2019.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Elisabeth Bedore Authorized Signatory Whippany, New Jersey 12/2/2019

This Amendment is to publicly disclose 6/30/19 holdings. Please note that this 13F Holdings Report filer is affiliated with MetLife Investment Management, LLC and Metropolitan Life Insurance Company who are also filing 13F Holdings Reports. Each entity is filing its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who is filing a 13F Notice Report.

Other Included Managers (1):

Num Name Location File Number
1 Metlife Inc New York, NY 028-18621